Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

InspireMD (NSPR) EBITDA Margin (2016 - 2025)

InspireMD (NSPR) has 16 years of EBITDA Margin data on record, last reported at 517.28% in Q3 2025.

  • For Q3 2025, EBITDA Margin fell 4977.0% year-over-year to 517.28%; the TTM value through Sep 2025 reached 602.87%, down 16387.0%, while the annual FY2024 figure was 478.0%, 13726.0% down from the prior year.
  • EBITDA Margin reached 517.28% in Q3 2025 per NSPR's latest filing, up from 732.23% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 284.86% in Q4 2021 and bottomed at 749.51% in Q1 2025.
  • Average EBITDA Margin over 5 years is 425.85%, with a median of 376.38% recorded in 2021.
  • Peak YoY movement for EBITDA Margin: soared 206831bps in 2021, then plummeted -25884bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 284.86% in 2021, then plummeted by -69bps to 481.09% in 2022, then soared by 31bps to 329.81% in 2023, then tumbled by -46bps to 480.61% in 2024, then dropped by -8bps to 517.28% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 517.28% in Q3 2025, 732.23% in Q2 2025, and 749.51% in Q1 2025.